Related Experiment Video
Updated: Jun 23, 2025

A Proinflammatory, Degenerative Organ Culture Model to Simulate Early-Stage Intervertebral Disc Disease.
Published on: February 14, 2021
Effects of circulating inflammatory proteins on spinal degenerative diseases: Evidence from genetic correlations and
Qingcong Zheng1, Rongjie Lin2, Du Wang3
1Department of Spinal Surgery The First Affiliated Hospital of Fujian Medical University Fuzhou China.
Insights
This study investigated causal links between circulating inflammatory proteins (CIPs) and spinal degenerative diseases (SDDs). Several CIPs were found to increase the risk of cervical spondylosis, disc prolapse, spinal stenosis, and spondylolisthesis.
Area of Science:
- Genetics
- Immunology
- Orthopedics
Background:
- Spinal degenerative diseases (SDDs) are common, with suspected links to circulating inflammatory proteins (CIPs).
- Causality between CIPs and SDDs remains unproven.
- Investigating these links can elucidate disease mechanisms and identify therapeutic targets.
Purpose of the Study:
- To investigate the causal associations between 91 CIPs and four common SDDs using Mendelian randomization.
- To identify specific CIPs that causally influence the risk of cervical spondylosis (CS), prolapsed disc/slipped disc (PD/SD), spinal canal stenosis (SCS), and spondylolisthesis/spondylolysis.
Main Methods:
- Utilized genome-wide association studies (GWAS) data for genetic variants of CIPs and SDDs.
- Employed Mendelian randomization (MR), with inverse variance weighted (IVW) as the primary analysis method.
- Performed pleiotropy and heterogeneity tests for robustness and reverse MR analysis to assess reverse causality.
Main Results:
- Identified causal effects of specific CIPs on SDD risk, including beta-nerve growth factor (β-NGF), CXCL6, and IL-6 for CS.
- Found FGF19, SULT1A1, and TNF-β associated with increased PD/SD risk, while u-PA showed a decreased risk.
- Revealed FGF19 and TNF linked to increased SCS risk, and STAMBP and CD6 isoform linked to increased spondylolisthesis/spondylolysis risk, with MCP2 and LAP-TGF-β1 showing decreased risk.
Conclusions:
- Established causal associations between multiple genetically predicted CIPs and the risk of four major SDDs.
- Provided reliable genetic evidence supporting the role of CIPs in the pathogenesis of SDDs.
- Highlighted novel potential therapeutic targets for SDDs based on identified CIPs.
Background:
Numerous investigations have suggested links between circulating inflammatory proteins (CIPs) and spinal degenerative diseases (SDDs), but causality has not been proven. This study used Mendelian randomization (MR) to investigate the causal associations between 91 CIPs and cervical spondylosis (CS), prolapsed disc/slipped disc (PD/SD), spinal canal stenosis (SCS), and spondylolisthesis/spondylolysis.
Methods:
Genetic variants data for CIPs and SDDs were obtained from the genome-wide association studies (GWAS) database. We used inverse variance weighted (IVW) as the primary method, analyzing the validity and robustness of the results through pleiotropy and heterogeneity tests and performing reverse MR analysis to test for reverse causality.
Results:
The IVW results with Bonferroni correction indicated that beta-nerve growth factor (β-NGF), C-X-C motif chemokine 6 (CXCL6), and interleukin-6 (IL-6) can increase the risk of CS. Fibroblast growth factor 19 (FGF19), sulfotransferase 1A1 (SULT1A1), and tumor necrosis factor-beta (TNF-β) can increase PD/SD risk, whereas urokinase-type plasminogen activator (u-PA) can decrease the risk of PD/SD. FGF19 and TNF can increase SCS risk. STAM binding protein (STAMBP) and T-cell surface glycoprotein CD6 isoform (CD6 isoform) can increase the risk of spondylolisthesis/spondylolysis, whereas monocyte chemoattractant protein 2 (MCP2) and latency-associated peptide transforming growth factor beta 1 (LAP-TGF-β1) can decrease spondylolisthesis/spondylolysis risk.
Conclusions:
MR analysis indicated the causal associations between multiple genetically predicted CIPs and the risk of four SDDs (CS, PD/SD, SCS, and spondylolisthesis/spondylolysis). This study provides reliable genetic evidence for in-depth exploration of the involvement of CIPs in the pathogenic mechanism of SDDs and provides novel potential targets for SDDs.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
The JAK-STAT Signaling Pathway
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

